Members
| Location: | Calgary, Alberta |
|---|---|
| Industry Sector: | Biotechnology - other |
| Website: | www.taigabioactives.com |
| Contact: |
John Hiebert (johnh@taigabioactives.com) 1 403 717 0776 |
| Description: | Taiga is a leading distributor, marketer, and developer of innovative consumer health solutions, using natural botanticals and other condition-specific products. Taiga’s proprietary product line is focused on unique botanicals that bring healthy, safe remedies to consumers which fulfill unmet market needs. |
| Location: | Mississauga, Ontario |
|---|---|
| Industry Sector: | Pharma |
| Website: | www.takedacanada.com |
| Contact: |
(info@takedacanada.com) 1 905 814 2300 |
| Ownership: | Subsidiary - Tokyo Stock Exchange (TSE): 4502 |
| Description: | Takeda is a research and development-driven pharmaceutical company. |
| Location: | Edmonton, Alberta |
|---|---|
| Industry Sector: | Public / Non-Profit Organizations |
| Website: | www.TECedmonton.com |
| Contact: |
Randy Yatscoff (info@TECedmonton.com) 1 780 492 8977 |
| Description: | TEC Edmonton helps inventors and entrepreneurs transform tech discoveries and business concepts into viable corporations. Through their business services, TEC Edmonton helps navigate the commercialization process providing technology licensing opportunities, as well as assistance with technology evaluation, intellectual property protection, business plan development, marketing research, corporate management and funding preparation. .A business accelerator, TEC Edmonton offers expertise, resources, experience and connections. A unique non-for-profit enterprise, TEC Edmonton is a joint venture between Edmonton Economic Development Corporation (EEDC) and the University of Alberta. |
| Location: | Santa Cruz, California |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.techvision.com |
| Contact: |
Robert Kilpatrick (rlkilpatrick@techvision.com) 1 831 4644230 |
| Description: | TVG is a life science networking company that is built on industry expertise and long-standing relationships. They provide their clients with the connections, the venues, and the access they need to succeed in a global life science world. |
| Location: | Montreal, Quebec |
|---|---|
| Industry Sector: | Pharma |
| Website: | tevacanadainnovation.com |
| Contact: |
Kevin C. Mannix (kevin.mannix@tevausa.com) 1 514 878 0095 |
| Ownership: | Subsidiary - NASDAQ: TEVA |
| Description: | Teva Canada Innovation's vision is to improve the health of Canadians through the quality of people, the benefits of products and focus on innovation. |
| Location: | Dorval, Quebec |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.thallion.com |
| Contact: |
Allan Mandelzys (amandelzys@thallion.com) 1 514 9403600 |
| Ownership: | Public - Toronto Stock Exchange (TSX): TLN.TO |
| Description: | Thallion Pharmaceuticals Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology, with a current emphasis on developing a treatment for Shigatoxin-producing E. coli (STEC) bacterial infections. |
| Location: | Montreal, Quebec |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.jblgroup.ca |
| Contact: |
Bernard Lachapelle (info@jbl.ca) 1 514 866 1551 |
| Description: | JBL Group is a multi-faceted consulting firm, specializing in Health Policy, Government Affairs and Access for the health care industry in Canada and abroad. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.pangaea-consultants.com |
| Contact: |
Joe Knott (info@pangaea-consultants.com) 1 416 5163524 |
| Description: | The Pangaea Group has extensive consulting & outsourcing experience in the Canadian Pharma market place. We add a broader, multi-faceted perspective that produces greater insight and results. |
| Location: | Mississauga, Ontario |
|---|---|
| Industry Sector: | Biotechnology / R&D Services |
| Website: | www.therapurebio.com |
| Contact: |
Nicholas Green (ceo@therapurebio.com) 1 905 2866200 |
| Description: | Therapure Biopharma Inc. is a Contract Development and Manufacturing Organization (CDMO) committed to the development, manufacture, purification, and packaging of high-quality biological therapeutics. The company offers: • GMP Biologic Manufacturing • Aseptic Fill/Finish and Lyophilization • Analytical Development and Testing • Technology Transfer and Development • Support Services The company develop and manufacture therapeutics for biopharmaceutical companies of all sizes and provide clients and partners with customized solutions for the development and manufacture of complex biological products, leveraging flexible, modern cGMP manufacturing facility, extensive quality systems and the dedication of highly experienced staff. |
| Location: | Montréal, Quebec |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.thrasos.com |
| Contact: |
(info@thrasos.com) 1 514 940 2714 |
| Description: | Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. Their lead product THR-184 is a peptide formulated for intravenous delivery. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.torys.com |
| Contact: |
Oriana Cheung (ocheung@torys.com) 1 416 8650040 |
| Description: | Torys LLP is a business law firm with 300 lawyers in its offices in New York and Toronto. Torys’ life sciences practice has expertise in corporate/commercial and intellectual property aspects of life sciences projects on both sides of the U.S.- Canada border. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.transitiontherapeutics.com |
| Contact: |
Tony Cruz (tcruz@transitiontherapeutics.com) 1 416 2607770 |
| Ownership: | Public - Toronto Stock Exchange (TSX): TTH.TO |
| Description: | Transition is a biopharmaceutical company developing novel therapeutics for disease indications with large markets. Their lead products include ELND005 for the treatment of Alzheimer's disease and TT223 for the treatment of diabetes. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.trilliumtherapeutics.com |
| Contact: |
Niclas Stiernholm (niclas@trilliumtherapeutics.com) 1 416 5950627 |
| Description: | Trillium Therapeutics Inc. (TTI) is a privately-owned, Toronto-based biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation. The Company's cytoprotection programs are based upon a recombinant form of heparin-binding epidermal growth factor-like growth factor (HB-EGF). In the immune regulation space, Trillium is developing a suite of innovate immunomodulatory products that are capable of either suppressing the immune system, for the treatment of autoimmunity, inflammation and hematopoietic stem cell transplantation (HSCT), or activating the immune system, for the treatment of cancer. Specifically, Trillium’s portfolio includes: • Two cytoprotective programs around TTI-1612, a recombinant growth factor that is being developed as a treatment for interstitial cystitis (IC) and for the prevention of necrotizing enterocolitis (NEC). Trillium recently commenced a single ascending dose trial in IC patients. • Three pre-clinical cancer programs, including a fully human CD200-specific monoclonal antibody, a Fc fusion protein CD47 antagonist, and a SIRPa agonist. |
